NCT05415098 2022-11-16Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasAscentage Pharma Group Inc.Phase 1 Unknown90 enrolled
NCT04107142 2019-09-27Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourCytoMed Therapeutics Pte LtdPhase 1 Unknown10 enrolled